You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pirfenidone

Showing 1 - 25 of 160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial (BI 1015550, Nintedanib, Pirfenidone)

Not yet recruiting
  • Healthy
  • BI 1015550
  • +2 more
  • (no location specified)
Oct 2, 2023

Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Pirfenidone
  • Placebo
  • Guangzhou, Guangdong, China
  • +4 more
Nov 16, 2023

COVID-19 Pneumonia Trial in Beijing (Pirfenidone Oral Product, Pirfenidone )

Active, not recruiting
  • COVID-19 Pneumonia
  • Pirfenidone Oral Product
  • Pirfenidone placebo
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Feb 3, 2023

Restrictive Chronic Lung Allograft Dysfunction, Lung Transplant Rejection Trial in San Francisco (Pirfenidone)

Completed
Has Results
  • Restrictive Chronic Lung Allograft Dysfunction
  • Lung Transplant Rejection
  • Pirfenidone
  • San Francisco, California
    University of California, San Francisco
Dec 13, 2022

Acute Respiratory Distress Syndrome (ARDS) Trial in Milan, Potenza (Pirfenidone, Placebo)

Recruiting
  • Acute Respiratory Distress Syndrome (ARDS)
  • Pirfenidone
  • Placebo
  • Milan, MI, Italy
  • +1 more
Dec 23, 2022

Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease Trial in Jinan (Pirfenidone, glucocorticoid and

Recruiting
  • Pirfenidone
  • +2 more
  • Pirfenidone
  • glucocorticoid and immunosuppressant
  • Jinan, Shandong, China
    Qilu Hospital
Aug 16, 2022

Novel Coronavirus-induced Lung Fibrosis Trial in Chandigarh (Pirfenidone, Nintedanib)

Active, not recruiting
  • Novel Coronavirus-induced Lung Fibrosis
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Sep 30, 2022

Pancreatitis, Acute Trial (Pirfenidone Oral Tablet, Placebo)

Not yet recruiting
  • Pancreatitis, Acute
  • Pirfenidone Oral Tablet
  • Placebo
  • (no location specified)
Apr 23, 2022

Acute Lung Injury, Prevention Trial (Pirfenidone/Placebo)

Not yet recruiting
  • Acute Lung Injury
  • Prevention
  • Pirfenidone/Placebo
  • (no location specified)
Jan 19, 2023

Covid19, ARDS Trial in Be'er Sheva (Pirfenidone, Standard of care)

Active, not recruiting
  • Covid19
  • ARDS
  • Pirfenidone
  • Standard of care
  • Be'er Sheva, Israel
    Soroka Medical Center
Jul 26, 2022

Healthy Trial in Neu-Ulm (Pirfenidone, GLPG4716, Nintedanib)

Completed
  • Healthy
  • Pirfenidone
  • +2 more
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jun 1, 2022

Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Prolonged-Release Pirfenidone
  • Guadalajara, Jalisco, Mexico
  • +1 more
Sep 13, 2022

Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])

Completed
  • Bronchiolitis Obliterans
  • Graft Vs Host Disease
  • Pirfenidone 267 MG [Esbriet]
  • Palo Alto, California
    Stanford University School of Medicine
Jun 8, 2022

Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Shanghai, China
    Shanghai Xuhui Central Hospital
May 12, 2022

Renal Insufficiency Trial in Wuhan (pirfenidone capsule)

Recruiting
  • Renal Insufficiency
  • pirfenidone capsule
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Mar 28, 2022

Pneumoconiosis Trial (Pirfenidone Capsules, capsules)

Not yet recruiting
  • Pneumoconiosis
  • Pirfenidone Capsules
  • placebo capsules
  • (no location specified)
Mar 16, 2022

Idiopathic Pulmonary Fibrosis Trial in Paris (18FDG-PET scan)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 18FDG-PET scan
  • Paris, France
    Service de Pneumologie A Centre constitutif de référence des mal
Oct 3, 2022

Pneumonitis, Malignant Tumor Trial in Guangzhou (Pirfenidone, methylprednisolone, Methylprednisolone)

Recruiting
  • Pneumonitis
  • Malignant Tumor
  • Guangzhou, Guangdong, China
    Zhou Chengzhi
Mar 6, 2022

Asbestosis Trial (Pirfenidone)

Not yet recruiting
  • Asbestosis
  • Pirfenidone
  • (no location specified)
Nov 24, 2021

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19

Completed
  • Post-COVID-19 Syndrome
  • Lung Fibrosis
  • Corticosteroids alone
  • +3 more
  • Mansoura, Dakahlia, Egypt
    Mansoura University
Dec 11, 2022

Dose Reduction and Discontinuation With Anti-Fibrotic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ridgefield, Connecticut
    Boehringer Ingelheim
Mar 24, 2023

Idiopathic Pulmonary Fibrosis Trial in Cincinnati (Esbriet 267 MG Oral Capsule, EXCL-100, 600 MG Oral Tablet)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Esbriet 267 MG Oral Capsule
  • EXCL-100, 600 MG Oral Tablet
  • (no location specified)
Jun 24, 2022

Lung Cancer Trial in Wuhan (Pirfenidone)

Recruiting
  • Lung Cancer
  • Pirfenidone
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Mar 24, 2023

Chronic Kidney Disease Trial in San Diego, San Francisco (Pirfenidone, matching )

Recruiting
  • Chronic Kidney Disease
  • Pirfenidone
  • matching placebo
  • San Diego, California
  • +1 more
Apr 25, 2022

NSCLC Stage IV, NSCLC, Recurrent Trial in Fairway, Kansas City (Atezolizumab)

Not yet recruiting
  • NSCLC Stage IV
  • NSCLC, Recurrent
  • Fairway, Kansas
  • +1 more
Jan 20, 2022